NP

Naynaben Patel

Active Director Managing Director DIN 02618779
DIN 02618779 First appointment Apr 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Apr 2009
Shareholding value •••• Premium profile

About Naynaben Patel

Data last updated:

Naynaben Patel is a Managing Director at Sat Kaival Hospital Private Limited (since 2009), Director at Zivia Healthcare Private Limited (since 2021) and Director at Zivia Pharmacy Private Limited (since 2021), and holds 4 more current directorships. The companies operate in Healthcare and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹48.81 Cr; the largest is Sat Kaival Hospital Private Limited at ₹36.08 Cr (FY 2023).

DIN 02618779
Primary Designation Managing Director
Industry Healthcare
First Appointment 20 Apr 2009
Oldest Company Age 17 yrs
Largest company Sat Kaival Hospital Private Limited · ₹36.08 Cr (FY 2023)
Combined revenue ₹48.81 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sat Kaival Hospital Private Limited U85110GJ2009PTC056671
Managing Director20 Apr 20092009₹36.08 Cr (FY 2023)Active
Zivia Healthcare Private Limited U85110MH2021PTC363758
Director12 Jul 20212021₹11.22 Cr (FY 2025)Active
Zivia Pharmacy Private Limited U52100MH2021PTC368016
Director23 Sep 20212021₹1.51 Cr (FY 2024)Active
Director25 Apr 20132013₹15,032 (FY 2025)Active
Director10 Sep 20252025Active
Savita Chhaya Foundation U85310GJ2016NPL094508
Director28 Nov 20162016Active
Akanksha Stemcell Private Limited U85110GJ2011PTC065846
Director10 Jun 20112011Active

Directorship timeline

Open interactive timeline →
Zivia Pharmacy Private Limited
Sat Kaival Hospital Private Limited
Akanksha Stemcell Private Limited
Zivia Healthcare Private Limited
Premium access

Shareholding and investment profile for Naynaben Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naynaben Patel

Naynaben Patel currently holds 7 directorships: Sat Kaival Hospital Private Limited (Managing Director, since 20 Apr 2009, revenue ₹36.08 Cr (FY 2023)); Zivia Healthcare Private Limited (Director, since 12 Jul 2021, revenue ₹11.22 Cr (FY 2025)); Zivia Pharmacy Private Limited (Director, since 23 Sep 2021, revenue ₹1.51 Cr (FY 2024)); Sat Kaival Medical Research Foundation (Director, since 25 Apr 2013, revenue ₹15,032 (FY 2025)); Rayos Anand Cancer Institute & Research Centre Private Limited (Director, since 10 Sep 2025); and 2 more.

Naynaben Patel was first appointed on 20 Apr 2009 as Managing Director at Sat Kaival Hospital Private Limited. The most recent appointment on record is 10 Sep 2025 at Rayos Anand Cancer Institute & Research Centre Private Limited.

The 4 current companies of Naynaben Patel that report revenue have a combined latest revenue of ₹48.81 Cr: Sat Kaival Hospital Private Limited ₹36.08 Cr (FY 2023); Zivia Healthcare Private Limited ₹11.22 Cr (FY 2025); Zivia Pharmacy Private Limited ₹1.51 Cr (FY 2024); Sat Kaival Medical Research Foundation ₹15,032 (FY 2025).

The current boards of Naynaben Patel's companies include Hiteshbhai Sumanbhai Patel (Sat Kaival Hospital Private Limited), Niket Hiteshbhai Patel (Sat Kaival Hospital Private Limited), Sanjay Jayasinh Mariwala (Zivia Healthcare Private Limited), Yash Mangal (Zivia Healthcare Private Limited), Gayatri Kumpawat (Rayos Anand Cancer Institute & Research Centre Private Limited), Priyanka Srivastava (Rayos Anand Cancer Institute & Research Centre Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available